Become a Member
  • Track your favourite stocks
  • Create & monitor portfolios
  • Daily portfolio value
Sign Up
Quickpicks
Add shares to your
quickpicks to
display them here!

Tristel (TSTL) Share Price

Price 425.00p on 03-08-2026 at 10:00:03
Change -1.00p -0.23%
Buy 430.00p
Sell 420.00p
Last Trade: Buy 163.00 at 425.90p
Day's Volume: 5,096
Last Close: 426.00p
Open: 427.50p
ISIN: GB00B07RVT99
Day's Range 425.00p - 427.50p
52wk Range: 350.00p - 450.00p
Market Capitalisation: £203.99m
VWAP: 424.88128p
Shares in Issue: 48.00m

Tristel (TSTL) Latest Trades

Buy/Sell Volume Trade Prc Trade Type Trade Time
Buy* 163 425.90p Ordinary
10:38:26 - 03-Aug-26
Sell* 399 423.00p Ordinary
10:30:48 - 03-Aug-26
Sell* 647 422.875p Ordinary
10:14:56 - 03-Aug-26
Buy* 468 425.90p Ordinary
10:07:11 - 03-Aug-26
Buy* 750 425.90p Ordinary
09:59:22 - 03-Aug-26
Buy* 500 430.00p Ordinary
09:33:50 - 03-Aug-26
Sell* 1,000 422.50p Ordinary
09:20:56 - 03-Aug-26
Buy* 4 430.00p SI Trade
08:47:49 - 03-Aug-26
Unknown* 0 430.00p SI Trade
08:47:49 - 03-Aug-26
Sell* 17 420.00p SI Trade
08:47:49 - 03-Aug-26
See more Tristel trades

Tristel (TSTL) Share Price History

Time period:
to
Date Open High Low Close Volume
31st Jul 2026 (Fri) 427.50 432.50 426.00 426.00 251,859
30th Jul 2026 (Thu) 422.50 430.00 430.00 430.00 186,776
29th Jul 2026 (Wed) 420.00 420.00 420.00 420.00 160,797
28th Jul 2026 (Tue) 410.00 420.00 410.00 420.00 243,214
27th Jul 2026 (Mon) 405.00 412.00 407.50 412.00 139,350
24th Jul 2026 (Fri) 392.50 450.00 450.00 450.00 63,136
23rd Jul 2026 (Thu) 390.00 392.50 390.00 392.50 115,883
22nd Jul 2026 (Wed) 400.00 400.00 380.00 390.00 78,450
21st Jul 2026 (Tue) 380.00 385.00 380.00 385.00 58,917
20th Jul 2026 (Mon) 380.00 380.00 380.00 380.00 101,159
17th Jul 2026 (Fri) 380.00 380.00 380.00 380.00 39,605
16th Jul 2026 (Thu) 382.50 380.00 375.00 380.00 449,513
15th Jul 2026 (Wed) 382.50 380.00 380.00 380.00 62,462
14th Jul 2026 (Tue) 384.00 384.00 382.50 382.50 146,882
13th Jul 2026 (Mon) 387.50 387.50 382.50 382.50 61,100
10th Jul 2026 (Fri) 392.50 394.00 387.50 387.50 31,330
9th Jul 2026 (Thu) 395.00 395.00 392.50 392.50 25,427
8th Jul 2026 (Wed) 392.50 392.50 392.50 392.50 14,436
7th Jul 2026 (Tue) 400.00 390.00 390.00 390.00 36,502
6th Jul 2026 (Mon) 400.00 400.00 400.00 400.00 110,380
3rd Jul 2026 (Fri) 400.00 400.00 396.00 400.00 67,912
See more Tristel price history

Tristel (TSTL) Regulatory News

Date Source Headline
31st Jul 2026 10:05 am RNS Exercise of Share Options and Total Voting Rights
27th Jul 2026 7:00 am RNS-R 3T Pro commercial launch
22nd Jul 2026 7:00 am RNS Positive Trading Update
7th Jul 2026 3:04 pm RNS Holding(s) in Company
7th Jul 2026 7:00 am RNS-R APIC26 Annual Conference attendance
17th Jun 2026 7:00 am RNS Appointment of CEO
16th Jun 2026 12:00 pm RNS Holding(s) in Company
10th Jun 2026 7:00 am RNS Exercise of Share Options & Total Voting Rights
13th May 2026 10:10 am RNS Exercise of Share Options and Total Voting Rights
5th May 2026 7:00 am RNS Exercise of Share Options and Total Voting Rights
See more Tristel regulatory news

Tristel (TSTL) Share News

TRADING UPDATES: Canal+ signs EUR980 million French cinema deal

27th Jul 2026 19:52

(Alliance News) - The following is a round-up of updates by London-listed companies, issued on Monday and not separately reported by Alliance News: Read More

WINNERS & LOSERS: Pinewood and Pharos back takeover offers

27th Jul 2026 10:23

(Alliance News) - The following are the leading risers and fallers among London Main Market small-cap and AIM stocks on Monday. Read More

IN BRIEF: Tristel names Christopher Lee as next chief executive

17th Jun 2026 15:40

Tristel PLC - Newmarket, England-based maker of infection prevention products - Appoints Christopher Lee as chief executive officer with effect from August 1, succeeding Matt Sassone, who is leaving on June 30. Names Chief Financial Officer Anna Wasyl to serve as interim CEO before Lee assumes the role. Says Sassone is moving to "a worldwide president role with a large US multinational." Lee was CEO of medical device company Summit Medical Ltd from 2020 to 2025. He is currently non-executive chair of Venner Medical Deutschland GmbH, having served as respiratory and anaesthesia products company Venner Medical International's CEO from 2013 to 2020, and worked at Johnson & Johnson for 18 years. Company says that at Summit he led its strategic development and growth, overseeing multiple subsidiaries and driving international expansion, and that overall he has more than 35 years' experience in the medical technology and healthcare industry. Read More

LONDON BROKER RATINGS: UBS raises BP; Berenberg cuts Antofagasta

16th Apr 2026 09:55

(Alliance News) - The following London-listed shares received analyst recommendations Thursday morning and on Wednesday: Read More

UK dividends calendar - next 7 days

2nd Apr 2026 12:07

Read More

See more Tristel news
FTSE 100 Latest
Value10,856.05
Change-12.00

Login to your account

Forgot Password?

Not Registered